In 1971, Knudson revealed, utilizing statistical analyses of the retinoblastoma incidence data, that two hits in an “anti-oncogene” are the rate-limiting steps in this disease [2]; this gene was later identified as the tumor suppressor RB1 [10]. This evidence concerns the gene RB1 and retinoblastoma.